Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9726
PUT
Wintrust Financial
WTFC
$10.3B
| $454K | ﹤0.01% |
6,000
+2,900
| +94% | +$227K |
|
|
SJR
9727
DELISTED
Shaw Communications Inc.
SJR
| $454K | ﹤0.01% |
15,706
-14,520
| -48% | -$419K |
|
|
FOLD
9728
PUT
DELISTED
Amicus Therapeutics
FOLD
| $453K | ﹤0.01% |
47,000
-214,100
| -82% | -$2.09M |
|
9729
PUT
Genprex
GNPX
$3.01M
| $453K | ﹤0.01% |
3
-3
| -50% | -$492K |
|
9730
PUT
Granite Construction
GVA
$5.44B
| $453K | ﹤0.01% |
10,900
-28,800
| -73% | -$1.14M |
|
9731
CALL
Enviri
NVRI
$628M
| $453K | ﹤0.01% |
22,200
+12,200
| +122% | +$251K |
|
9732
United States Antimony
UAMY
$726M
| $453K | ﹤0.01% |
458,752
+69,428
| +18% | +$64.4K |
|
9733
CALL
VOC Energy
VOC
$55.9M
| $453K | ﹤0.01% |
95,700
+50,000
| +109% | +$196K |
|
|
JJT
9734
DELISTED
iPath Series B Bloomberg Tin Subindex Total ReturnSM ETN
JJT
| $453K | ﹤0.01% |
4,942
+192
| +4% | +$16K |
|
9735
CALL
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.75B
| $452K | ﹤0.01% |
8,300
-700
| -8% | -$37.3K |
|
9736
Escalade
ESCA
$278M
| $452K | ﹤0.01% |
19,691
-736
| -4% | -$16.9K |
|
9737
Greif
GEF
$4.78B
| $452K | ﹤0.01% |
+7,459
| New | +$456K |
|
9738
Local Bounti
LOCL
$23.2M
| $452K | ﹤0.01% |
+3,521
| New | +$450K |
|
9739
CALL
Arcadia Biosciences
RKDA
$1.28M
| $452K | ﹤0.01% |
3,811
-12,578
| -77% | -$1.37M |
|
9740
CALL
Tactile Systems Technology
TCMD
$525M
| $452K | ﹤0.01% |
8,700
-1,000
| -10% | -$54.1K |
|
|
APRN
9741
CALL
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $452K | ﹤0.01% |
8,800
+5,017
| +133% | +$319K |
|
|
ATIP
9742
PUT
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $452K | ﹤0.01% |
948
+532
| +128% | +$263K |
|
9743
PUT
Ameris Bancorp
ABCB
$5.74B
| $451K | ﹤0.01% |
8,900
+4,500
| +102% | +$242K |
|
9744
Astec Industries
ASTE
$999M
| $451K | ﹤0.01% |
7,171
+3,575
| +99% | +$250K |
|
9745
Armstrong World Industries
AWI
$7.4B
| $451K | ﹤0.01% |
4,201
-2,626
| -38% | -$270K |
|
9746
CALL
Curtiss-Wright
CW
$22B
| $451K | ﹤0.01% |
3,800
+1,400
| +58% | +$175K |
|
9747
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$822M
| $451K | ﹤0.01% |
15,410
-86,830
| -85% | -$2.46M |
|
9748
PUT
Utz Brands
UTZ
$1.26B
| $451K | ﹤0.01% |
20,700
-80,900
| -80% | -$2.02M |
|
|
CHS
9749
PUT
DELISTED
Chicos FAS, Inc.
CHS
| $451K | ﹤0.01% |
68,500
-283,000
| -81% | -$1.22M |
|
|
VRS
9750
PUT
DELISTED
Verso Corporation
VRS
| $451K | ﹤0.01% |
25,500
-2,400
| -9% | -$39.6K |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.